Italy vs Spain: HIV/AIDS deaths averted by antiretroviral therapy
Italy
4,048 deaths
in 2024
Spain
3,213 deaths
in 2024
Italy rank
45th
Spain rank
48th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Italy
- Spain
How they compare
Italy currently reports 4,048 deaths against 3,213 deaths in Spain, a difference of 835 deaths.
That makes Italy's figure about 1.3 times Spain's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Spain ahead.
Italy ranks 45th and Spain ranks 48th of 157 countries.
Across the 4 decades both report, Italy averaged higher in 2 and Spain in 2.
Head to head by decade
| Decade | Italy | Spain | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 710.23 deaths | 1,429 deaths | 718.4 deaths | Spain |
| 2000s | 4,451 deaths | 5,789 deaths | 1,337 deaths | Spain |
| 2010s | 4,398 deaths | 4,277 deaths | 121.11 deaths | Italy |
| 2020s | 4,155 deaths | 3,345 deaths | 809.93 deaths | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Italy or Spain?
- Italy, at 4,048 deaths against 3,213 deaths in Spain as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Italy and Spain?
- 835 deaths, with Italy ahead.
- How many years of comparable data are there for Italy and Spain?
- 35 years are reported by both, from 1990 to 2024.
- How do Italy and Spain rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Italy ranks 45th and Spain ranks 48th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.